OBJECTIVES: To determine whether percentages of CD4(+)CD25(high) T cells (a group of regulatory T cells, Treg) differ in patients with multiple sclerosis (MS) in relapse vs remission after glucocorticoid treatment and whether treatment for relapses changes Treg population and the expression of Foxp3, a key Treg-associated molecule. MATERIALS AND METHODS: Peripheral blood mononuclear cells (PBMC) were obtained from 20 patients with MS during relapse, just before and 2 days after starting steroid treatment (i.v. methylprednisolone 1 g/day for 3 days) and then 6 weeks after treatment. CD4(+)CD25(hi) cells were analysed by using flow cytometry. Cytokines were measured by using an ELISA and Foxp3, CD3 and CD25 expression by using quantitative real-time PCR. RESULTS: The percentage of CD4(+)CD25(hi) cells, plasma IL-10 and Foxp3/CD3 ratio increased 48 h after methylprednisolone initiation and returned to baseline values by 6 weeks post-treatment. CONCLUSIONS: Results suggest that glucocorticoids increase Treg cell functional molecules and percentages. This may be a mechanism whereby steroids expedite recovery from MS relapses.
OBJECTIVES: To determine whether percentages of CD4(+)CD25(high) T cells (a group of regulatory T cells, Treg) differ in patients with multiple sclerosis (MS) in relapse vs remission after glucocorticoid treatment and whether treatment for relapses changes Treg population and the expression of Foxp3, a key Treg-associated molecule. MATERIALS AND METHODS: Peripheral blood mononuclear cells (PBMC) were obtained from 20 patients with MS during relapse, just before and 2 days after starting steroid treatment (i.v. methylprednisolone 1 g/day for 3 days) and then 6 weeks after treatment. CD4(+)CD25(hi) cells were analysed by using flow cytometry. Cytokines were measured by using an ELISA and Foxp3, CD3 and CD25 expression by using quantitative real-time PCR. RESULTS: The percentage of CD4(+)CD25(hi) cells, plasma IL-10 and Foxp3/CD3 ratio increased 48 h after methylprednisolone initiation and returned to baseline values by 6 weeks post-treatment. CONCLUSIONS: Results suggest that glucocorticoids increase Treg cell functional molecules and percentages. This may be a mechanism whereby steroids expedite recovery from MS relapses.
Authors: Roger P M Sutmuller; Mary E Morgan; Mihai G Netea; Oliver Grauer; Gosse J Adema Journal: Trends Immunol Date: 2006-06-30 Impact factor: 16.687
Authors: Angela J Fahey; R Adrian Robins; Karin B Kindle; David M Heery; Cris S Constantinescu Journal: J Leukoc Biol Date: 2006-05-02 Impact factor: 4.962
Authors: J A Cohen; P A Calabresi; S Chakraborty; K R Edwards; T Eickenhorst; W L Felton; E Fisher; R J Fox; A D Goodman; C Hara-Cleaver; G J Hutton; P B Imrey; D M Ivancic; B F Mandell; J E Perryman; T F Scott; T T Skaramagas; H Zhang Journal: Mult Scler Date: 2008-01-21 Impact factor: 6.312
Authors: Simone Wüst; Jens van den Brandt; Denise Tischner; Anna Kleiman; Jan P Tuckermann; Ralf Gold; Fred Lühder; Holger M Reichardt Journal: J Immunol Date: 2008-06-15 Impact factor: 5.422
Authors: Laszlo Kari; Andrey Loboda; Michael Nebozhyn; Alain H Rook; Eric C Vonderheid; Calen Nichols; Dezso Virok; Celia Chang; Wen-Hwai Horng; James Johnston; Maria Wysocka; Michael K Showe; Louise C Showe Journal: J Exp Med Date: 2003-06-02 Impact factor: 14.307
Authors: Jorge Paz Rodriguez; Michael P Murphy; Soonjun Hong; Marialaura Madrigal; Keith L March; Boris Minev; Robert J Harman; Chien-Shing Chen; Ruben Berrocal Timmons; Annette M Marleau; Neil H Riordan Journal: Int Arch Med Date: 2012-02-08
Authors: Nicola Eastaff-Leung; Nicholas Mabarrack; Angela Barbour; Adrian Cummins; Simon Barry Journal: J Clin Immunol Date: 2010-01 Impact factor: 8.317
Authors: C De Andres; M I García; H Goicoechea; M L Martínez-Ginés; J M García-Domínguez; M L Martín; F Romero-Delgado; A Benguría; M Sanjurjo; L A López-Fernández Journal: Pharmacogenomics J Date: 2016-09-27 Impact factor: 3.550
Authors: Coco de Koning; Susan Prockop; Ichelle van Roessel; Nancy Kernan; Elizabeth Klein; Jurgen Langenhorst; Celina Szanto; Mirjam Belderbos; Marc Bierings; Farid Boulad; Dorine Bresters; Maria Cancio; Kevin Curran; Wouter Kollen; Richard O'Reilly; Andromachi Scaradavou; Barbara Spitzer; Birgitta Versluijs; Alwin Huitema; Caroline Lindemans; Stefan Nierkens; Jaap Jan Boelens Journal: Blood Date: 2021-02-11 Impact factor: 22.113
Authors: SuJin Hwang; Christina Tatsi; Hye Sun Kuehn; Julie E Niemela; Jennifer Stoddard; Yan Su; Maya Lodish; Gulbu Uzel; Rosanne Spolski; Warren J Leonard; Steven M Holland; Thomas A Fleisher; Constantine A Stratakis; Sergio D Rosenzweig Journal: J Allergy Clin Immunol Date: 2021-06-02 Impact factor: 10.793